FTCM
GBT

First Trust Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

First Trust Capital Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-349,165
Closed -$23.8M – 522
2022
Q3 		$23.8M Buy
+349,165
New +$19.3M 1.12% 9

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

First Trust Capital Management's GBT Position: Q4 2022 in Review

First Trust Capital Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 349,165 shares — an estimated $23.8M sold.

First Trust Capital Management first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $23.8M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • First Trust Capital Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • First Trust Capital Management sold 349,165 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $23.8M.
  • First Trust Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • First Trust Capital Management's Global Blood Therapeutics, Inc. position peaked at $23.8M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on First Trust Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.